Specialty healthcare consulting firm that advises large physician groups, hospitals, and investors through industry and business transitions by providing strategic, operational, and financial consulting. Create purpose-driven systems, models, and value for providers and investors that build a sustainable legacy in patient care. Provide in-depth market research in aesthetics, oncology, orthopedics, dermatology, and other specialty areas.➣ Launched VMG to expand work outside urology and assist medical providers in practice valuations, payor contracting, bundled payments market research, and analysis for pharmaceutical and medical device companies.➣ Expanded the practice to include M&A niche consultation, PE and investment banking partnerships, and medical practice “roll-up” advisory services to help medical practice clients strategically and successfully navigate market consolidation/transformation. Services include medical practice valuations, M&A document preparation and deal-flow consulting, revenue optimization, operational efficiencies, market research, financial benchmarking, provider compensation, payor contracting, alternative payment options, data analytics, and process improvements.➣ Advised PE groups in evaluating investments in specialty areas through market research, analysis, measurement and analytics, business intelligence, and an extensive network of physicians/key opinion leaders.➣ Provided subject matter expertise and thought leadership, including market insights (whitepapers, podcasts, blog articles) and keynote presentations and panel discussions, both live and virtual, at medical forums, summits, and conferences, educating audiences across a broad spectrum of topics such as transformations in healthcare, PE investments, practice efficiency techniques, staff management, succession planning, financial benchmarking, marketing, advancing technology, and more.

Sold previous company, DJI Consulting, to a PE firm that merged DIJI with a urology group purchasing business (UroGPO) and a data analytics platform (PPS Analytics) to create a full-service specialty healthcare consulting and industry leader in urology market research and project management for industry and medical groups.➣ Oversaw urology consulting practice, including project management and client leadership for new and developed markets in the US and abroad. Responsible for providing UroGPO members and physicians with critical insights for urology patient care in prostate, bladder, and kidney cancer, Peyronie’s disease, overactive bladder, prostate prostatic hyperplasia, and other conditions.➣ Worked with 75% of community-based urology groups in the US and with pharmaceutical and device companies with a focus on strategy and planning.➣ Client engagements addressed medical practice consolidations and mergers, patient engagement/retention strategies, development of inventory management and supply chain best practices, organizational development and effectiveness initiatives, compensation, ancillary service models, lean processes/methodologies, development and implementation of practice management structures, and rebranding strategies.➣ Provided data that enhanced policy and procedures across reimbursement and best practices.➣ Improved urology patient outcomes by developing standardized programs for treatment.➣ International keynote speaker and subject matter expert at medical forums, summits, and conferences.➣ Specialty Networks LLC was sold in 2020 in a larger PE transaction.

Founded this specialty urology and uro-oncology consulting firm focusing on providing market research, analysis, insights, and business intelligence to pharmaceutical and medical device clients, often preparing for product launches.➣ Secured clients, including Johnson & Johnson Corporation (J&J), Pfizer Inc., Renovia Inc., Endo Pharmaceuticals Pharmaceutical Company, and Clovis Oncology Pharmaceutical Company.➣ Developed an extensive network of physicians and medical practitioners in urology practices in the US.➣ Therapeutic focus areas included prostate cancer, overactive bladder, and bladder cancer.

Recruited to this specialty healthcare firm providing practice management consulting and compliance expertise to ophthalmology and medical aesthetic specialties. Led consulting engagements and medical market research for medical practices and pharmaceutical and medical device clients across the US, Europe, and Asia, focusing on new market development, medical practice management, provider compensation strategies, efficiency metrics, and process improvements.➣ Managed $2.5M of client engagements, including the launch of Allergan’s Botox in Asia in 2015.➣ Introduced Lean Six Sigma methods to practice management to reduce costs and achieve efficiency across the practice.➣ Keynote speaker and SME at medical forums and conferences focusing on practice efficiency techniques, staff management, financial benchmarking, and marketing search engine optimization (SEO) strategies.

Recruited to this newly formed hospital asset-optimizing division of GE’s $16.9B (2010) healthcare business and managed a 25-person consulting team.➣ Managed multimillion-dollar engagements to help client hospitals strengthen profit, productivity, and efficiency through process improvement, change management, and implementation of accountability standards.➣ Based on outstanding performance, selected by senior management as national lead for project development, analysis, implementation, and delivery at more than 25 Universal Health Services, Inc. (UHS) hospitals and select Health Corporation of America (HCA) health system sites.➣ Defined engagement requirements with hospital administrators, managers, and staff; evaluated operations, assets, and efficiency gaps; and designed and implemented deliverables to improve costs, processes, and employee satisfaction.➣ Increased return on investment (ROI) and compound annual growth rate (CAGR) by managing and recommending changes in processing methods, alternate procedures, equipment modifications, and redesigns of products, services, and staffing models.

Recruited to this $1.6B American, Irish-domiciled specialty pharmaceutical and medical device company. Specialty pharmaceuticals included eye care, BOTOX®/neuromodulator, skin care, and urologics. Medical device products included breast aesthetics, obesity intervention, and facial aesthetics.➣ Drove year-over-year sales and market share growth of 45%; launched product lines in Elizabeth Arden Red Door Spas, Johns Hopkins medical facilities, NIH facilities, and TLC Laser Corporation sites.➣ Developed new business and cultivated strategic partnerships through patient education events, seminars, customer/PR strategies, patient education tools, speaker programs, and practice-specific retention programs.➣ Grew ROI with developed accounts from 50% to 60%; developed business plans and analyses and staff training initiatives.➣ Keynote speaker at national plastic surgery and dermatology conferences.

➣ Managed engagements with physicians; conducted analyses of patient flow, business models, marketing strategies, staff training/development, and other metrics to help improve revenue, profit, and patient acquisition and retention.➣ Achieved revenue growth of 40% year-over-year in key client accounts through patient-targeted marketing campaigns.➣ Earned Leadership Council and Presidents Club in 2008 and 2009.➣ Authored articles published in national medical journals, including “Practical Dermatology” and “Plastic Surgery News.”➣ Invited keynote speaker at national plastic surgery and dermatology conferences on SEO strategies, marketing, patient retention, and financial benchmarking and analysis.

Recruited by GE Healthcare Technologies to lead the rapid turnaround of a territory that had experienced zero sales in the previous 16 months. As a Cardiovascular Ultrasound Account Executive, Dana converted top-tier hospitals and unseated entrenched world-class competitors.➣ Converted top-tier hospitals to GE product line; sold 7 systems to Johns Hopkins and won business with the University of Maryland Health Systems, Washington Hospital Center, Walter Reed Army Medical Center, and NIH.➣ Selected #1 candidate in the sales training program for the ultrasound division’s Lean Six Sigma Green Belt.➣ Negotiated pricing, technologies, and product configurations with C-level decision-makers.

Joined Johnson & Johnson as a Central Nervous System (CNS) Specialty & Urology Pharmaceutical Sales Executive. Transformed underpreforming territory; achieved the top representative award, #1 out of 182 sales representatives nationwide in 2004. ➣ Recruited to the pharmaceutical division of this $36.3B (2002) parent company to sell CNS specialty and urology products.➣ Ranked #2 sales representative among 55 in the region in the second quarter of 2003.➣ Achieved Sales Representative of the Second Cycle Regional Award for 2 consecutive years, 2003 and 2004.➣ Completed J&J management development program.➣ Led supervisory efforts and reoriented approach to client management and execution of sound principles.